FDA NDC Directory · JSON-LD · Markdown

TADLIQ

NDC 46287-045 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameTadalafil
Labeler / ManufacturerCMP Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214522
Dosage form / routeSUSPENSION · ORAL
Active ingredientsTADALAFIL (20 mg/5mL)
Marketing started20220830
Package count1

External sources

Source: openFDA. Public-domain (CC0).